Cargando…
ALBAE feature extraction based lung pneumonia and cancer classification
Lung cancer is a deadly disease showing uncontrolled proliferation of malignant cells in the lungs. If the lung cancer is detected in early stages, it can be cured before critical stage. In recent years, new technologies have gained much attention in the healthcare industry however, the unpredictabl...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187954/ https://www.ncbi.nlm.nih.gov/pubmed/37362264 http://dx.doi.org/10.1007/s00500-023-08453-w |
Sumario: | Lung cancer is a deadly disease showing uncontrolled proliferation of malignant cells in the lungs. If the lung cancer is detected in early stages, it can be cured before critical stage. In recent years, new technologies have gained much attention in the healthcare industry however, the unpredictable appearance of tumors, finding their presence, determining its shape, size and high discrepancy in medical images are the challenging tasks. To overcome this issue a novel Ant lion-based Autoencoders (ALbAE) model is proposed for efficient classification of lung cancer and pneumonia. Initially Computed Tomography (CT) images are pre-processed using median filters to remove noise artifacts and improving the quality of the images. Consequently, the relevant features such as image edges, pixel rates of the images and blood clots are extracted by ant lion-based autoencoder (ALbAE) technique. Finally, in classification stage, the lung CT images are classified into three different categories such as normal lung, cancer affected lung and pneumonia affected lung using Random forest technique. The effectiveness of the implemented design is estimated by different parameters such as precision, recall, Accuracy and F1-measure. The proposed approach attains 97% accuracy; 98% of recall and F-measure rate is attained through the developed design and the proposed model gains 96% of precision score. Experimental outcomes show that the proposed model performs better than existing SVM, ELM, and MLP in classifying lung cancer and pneumonia. |
---|